In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus

scientific article

In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.33.4.576
P932PMC publication ID172483
P698PubMed publication ID2543285
P5875ResearchGate publication ID20613437

P2093author name stringYoshida S
Itoh T
Nagai Y
Ogura M
Inoue T
Hotta T
Saitoh H
Tomoda Y
Saneyoshi M
Tsushita K
P2860cites work3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroQ24609215
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosidesQ28360374
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialQ29620805
Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).Q33444047
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complexQ34558599
Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitroQ35537911
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analoguesQ42206512
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agentsQ42216602
Effects of 2?,3?-dideoxynucleosides on mammalian cells and virusesQ42817621
Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosomeQ42819189
Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin AQ47878288
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.Q55243911
Functional and morphological differentiation induction of a human megakaryoblastic leukemia cell line (MEG-01s) by phorbol diestersQ69031908
The growth of mouse bone marrow cells in vitroQ70071283
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)576-579
P577publication date1989-04-01
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleIn vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus
P478volume33

Reverse relations

cites work (P2860)
Q398657533'-azido-3'-deoxythymidine (AZT) monophosphate: an inhibitor of exonucleolytic repair of AZT-terminated DNA
Q33502564Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity
Q28323830Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells
Q40487963Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).
Q33933498Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics
Q44916797Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production
Q36646145Hematologic Effects of AIDS Therapies
Q45229763Hematological effects of 2',3'-dideoxycytidine in rabbits
Q33395770In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model
Q84696065In vitro studies of the toxicity of nucleoside analogues used in the treatment of HIV infection
Q41129035Megakaryocytic cell lines
Q30414740Neurotoxic effects of AZT on developing and adult neurogenesis
Q28321882Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine
Q41155364Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection
Q41394569The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy

Search more.